Redox‐Responsive Nanobiomaterials‐Based Therapeutics for Neurodegenerative Diseases. Issue 43 (17th September 2020)

• Record Type: Journal Article
• Authors: Eleftheriadou, Despoina; Kesidou, Despoina; Moura, Francisco; Felli, Eric; Song, Wenhui
• Is Part Of: Small. Volume 16:Issue 43(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-09-17
• Subjects: antioxidants -- nanocomplexes -- nanomaterials -- neurodegenerative diseases -- oxidative stress; Nanotechnology -- Periodicals; Nanoparticles -- Periodicals; Microtechnology -- Periodicals; 620.5
• DOI: 10.1002/smll.201907308
• Languages: English
• ISSNs: 1613-6810

Abstract

Abstract: Redox regulation has recently been proposed as a critical intracellular mechanism affecting cell survival, proliferation, and differentiation. Redox homeostasis has also been implicated in a variety of degenerative neurological disorders such as Parkinson's and Alzheimer's disease. In fact, it is hypothesized that markers of oxidative stress precede pathologic lesions in Alzheimer's disease and other neurodegenerative diseases. Several therapeutic approaches have been suggested so far to improve the endogenous defense against oxidative stress and its harmful effects. Among such approaches, the use of artificial antioxidant systems has gained increased popularity as an effective strategy. Nanoscale drug delivery systems loaded with enzymes, bioinspired catalytic nanoparticles and other nanomaterials have emerged as promising candidates. The development of degradable hydrogels scaffolds with antioxidant effects could also enable scientists to positively influence cell fate. This current review summarizes nanobiomaterial‐based approaches for redox regulation and their potential applications as central nervous system neurodegenerative disease treatments. Abstract : Oxidative stress has recently been highlighted as a critical intracellular mechanism affecting cell survival and function. Redox homeostasis has also been implicated in a variety of degenerative neurological disorders such as Parkinson's and Alzheimer's disease. This article summarizes nanobiomaterial‐based approaches for redox regulation and their potential applications as treatments against central nervous system neurodegenerative diseases.